300 related articles for article (PubMed ID: 20687782)
1. Overview perspective of bacterial resistance.
Furtado GH; Nicolau DP
Expert Opin Ther Pat; 2010 Oct; 20(10):1273-6. PubMed ID: 20687782
[TBL] [Abstract][Full Text] [Related]
2. Pathogens resistant to antibacterial agents.
Chen LF; Chopra T; Kaye KS
Infect Dis Clin North Am; 2009 Dec; 23(4):817-45, vii. PubMed ID: 19909886
[TBL] [Abstract][Full Text] [Related]
3. Trends in antimicrobial resistance in health care-associated pathogens and effect on treatment.
McDonald LC
Clin Infect Dis; 2006 Jan; 42 Suppl 2():S65-71. PubMed ID: 16355319
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
[TBL] [Abstract][Full Text] [Related]
5. Bacterial pathogens (non-Mycobacterium) from sputum culture and antimicrobial susceptibility.
Srifuengfung S; Sangsawang M; Komolpis P; Dhiraputra C; Chompanee B
Southeast Asian J Trop Med Public Health; 1998 Mar; 29(1):96-9. PubMed ID: 9740278
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
[TBL] [Abstract][Full Text] [Related]
7. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003.
Wu CJ; Lee HC; Lee NY; Shih HI; Ko NY; Wang LR; Ko WC
J Microbiol Immunol Infect; 2006 Apr; 39(2):135-43. PubMed ID: 16604246
[TBL] [Abstract][Full Text] [Related]
8. The growing burden of antimicrobial resistance.
Hawkey PM
J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i1-9. PubMed ID: 18684701
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007).
Nørskov-Lauritsen N; Marchandin H; Dowzicky MJ
Int J Antimicrob Agents; 2009 Aug; 34(2):121-30. PubMed ID: 19342205
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial resistance in Europe and its potential impact on empirical therapy.
Rossolini GM; Mantengoli E
Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():2-8. PubMed ID: 19040461
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of ertapenem: review of recent studies.
Wexler HM
J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179
[TBL] [Abstract][Full Text] [Related]
12. Microbiology of diabetic foot infections in a teaching hospital in Malaysia: a retrospective study of 194 cases.
Raja NS
J Microbiol Immunol Infect; 2007 Feb; 40(1):39-44. PubMed ID: 17332905
[TBL] [Abstract][Full Text] [Related]
13. Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?
Falagas ME; Bliziotis IA
Int J Antimicrob Agents; 2007 Jun; 29(6):630-6. PubMed ID: 17306965
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of tigecycline and comparator agents against a global collection of Gram-negative and Gram-positive organisms: tigecycline Evaluation and Surveillance Trial 2004 to 2007.
Garrison MW; Mutters R; Dowzicky MJ
Diagn Microbiol Infect Dis; 2009 Nov; 65(3):288-99. PubMed ID: 19733459
[TBL] [Abstract][Full Text] [Related]
15. Resistance patterns among selective Gram-negative bacilli from an intensive care unit in Trinidad, West Indies.
Orrett FA
Saudi Med J; 2004 Apr; 25(4):478-83. PubMed ID: 15083220
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of tigecycline against 2423 clinical isolates and comparison of the available interpretation breakpoints.
Papaparaskevas J; Tzouvelekis LS; Tsakris A; Pittaras TE; Legakis NJ;
Diagn Microbiol Infect Dis; 2010 Feb; 66(2):187-94. PubMed ID: 19836184
[TBL] [Abstract][Full Text] [Related]
17. Frequency of isolation and antimicrobial susceptibility of bacteria isolated from bloodstream infections at Children's Medical Center, Tehran, Iran, 1996-2000.
Mamishi S; Pourakbari B; Ashtiani MH; Hashemi FB
Int J Antimicrob Agents; 2005 Nov; 26(5):373-9. PubMed ID: 16213124
[TBL] [Abstract][Full Text] [Related]
18. Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in Italy.
Roveta S; Marchese A; Debbia EA
Chemotherapy; 2008; 54(1):43-9. PubMed ID: 18073470
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan.
Sheng WH; Wang JT; Chen YC; Chang SC; Luh KT
J Microbiol Immunol Infect; 2001 Sep; 34(3):178-84. PubMed ID: 11605808
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial drug resistance in Taiwan.
Huang YT; Hsueh PR
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S174-8. PubMed ID: 19013350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]